Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online January 18, 2007
This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
2006-0540v1
25/5/1126    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hedlund, E.
Right arrow Articles by Kim, K.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hedlund, E.
Right arrow Articles by Kim, K.-S.
Submitted on August 29, 2006
Accepted on January 9, 2007

Embryonic Stem Cells

Selection of embryonic stem cell derived eGFP+ dopamine neurons using the tyrosine hydroxylase promoter is confounded by reporter gene expression in immature cell populations

Eva Hedlund 1, Jan Pruszak 2, Andrew Ferree 2, Angel Viñuela 2, Sunghoi Hong 2, Ole Isacson 2, Kwang-Soo Kim 3*

1 Udall Parkinson's Disease Research Center for Excellence, McLean Hospital/Harvard Medical School, Belmont, Massachusetts; Molecular Neurobiology Laboratories, McLean Hospital/Harvard Medical School, Belmont, Massachusetts; Neuroregeneration Laboratories, McLean Hospital/Harvard Medical School, Belmont, Massachusetts
2 Udall Parkinson's Disease Research Center for Excellence, McLean Hospital/Harvard Medical School, Belmont, Massachusetts; Neuroregeneration Laboratories, McLean Hospital/Harvard Medical School, Belmont, Massachusetts
3 Udall Parkinson's Disease Research Center for Excellence, McLean Hospital/Harvard Medical School, Belmont, Massachusetts; Molecular Neurobiology Laboratories, McLean Hospital/Harvard Medical School, Belmont, Massachusetts

* To whom correspondence should be addressed. E-mail: kskim{at}mclean.harvard.edu.


   Abstract

Transplantation of mouse embryonic stem (mES) cells can restore function in Parkinson's disease models, but can generate teratomas. Purification of dopamine neurons derived from ES cells by fluorescence activated cell sorting (FACS) could provide a functional cell population for transplantation, while eliminating the risk of teratoma formation. Here we used the tyrosine hydroxylase (TH) promoter to drive eGFP expression in mES cells. First, we evaluated 2.5 kb and 9 kb TH promoter fragments and showed that clones generated using the 9 kb fragment produced significantly more eGFP+/TH+ neurons. We selected the 9 kb TH clone with highest eGFP/TH overlap for further differentiation, FACS and transplantation experiments. Grafts contained large numbers of eGFP+ dopamine neurons of an appropriate phenotype. However, there were also numerous eGFP+ cells that did not express TH and did not have a neuronal morphology. In addition, we found cells in the grafts representing all three germ layers. Based on these findings we examined the expression of stem cell markers in our eGFP+ population. We found that a majority of eGFP+ cells were SSEA-1+ and that the genetically engineered clones contained more SSEA-1+ cells after differentiation than the original D3 mES cells. By negative selection of SSEA-1 we could isolate a neuronal eGFP+ population of high purity. These results illustrate the complexity of using genetic selection to purify mES cell derived dopamine neurons and provide a comprehensive analysis of cell selection strategies based on tyrosine hydroxylase expression.

Key Words. stem cells, genetic engineering, fluorescence activated cell sorting (FACS), Parkinson's disease (PD), stage-specific embryonic antigen 1 (SSEA-1)




This article has been cited by other articles:


Home page
Stem CellsHome page
E. Hedlund, J. Pruszak, T. Lardaro, W. Ludwig, A. Vinuela, K.-S. Kim, and O. Isacson
Embryonic Stem Cell-Derived Pitx3-Enhanced Green Fluorescent Protein Midbrain Dopamine Neurons Survive Enrichment by Fluorescence-Activated Cell Sorting and Function in an Animal Model of Parkinson's Disease
Stem Cells, June 1, 2008; 26(6): 1526 - 1536.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M. Wernig, J.-P. Zhao, J. Pruszak, E. Hedlund, D. Fu, F. Soldner, V. Broccoli, M. Constantine-Paton, O. Isacson, and R. Jaenisch
Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease
PNAS, April 15, 2008; 105(15): 5856 - 5861.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
J. Pruszak, K.-C. Sonntag, M. H. Aung, R. Sanchez-Pernaute, and O. Isacson
Markers and Methods for Cell Sorting of Human Embryonic Stem Cell-Derived Neural Cell Populations
Stem Cells, September 1, 2007; 25(9): 2257 - 2268.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS
http://www.peprotech.com/
Copyright © 2007 by AlphaMed Press.